Friedreich ataxia trials in United States
16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of SGT-212 Gene Therapy in Friedreich's Ataxia
- Where
- Columbus, Los Angeles, Philadelphia
- Age
- 18 years to 40 years
- People
- 10
- Run by
- Solid Biosciences Inc.
See details and how to joinNCT07180355 - No phaseTaking peopleRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Where
- Sioux Falls
- People
- 20,000
- Run by
- Sanford Health
See details and how to joinNCT01793168 - Phase 2Taking peopleAn Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
- Where
- Chevy Chase, Columbus, Eatontown, Gainesville, Iowa City, Los Angeles, Philadelphia, Salt Lake City, San Francisco, Tampa
- Age
- 2 years to 60 years
- People
- 85
- Run by
- Larimar Therapeutics, Inc.
See details and how to joinNCT06447025 - No phaseTaking peopleClinical Course Of Disease In Participants With FA-CM
- Where
- Boston, Cincinnati, Indianapolis, La Jolla, Portland, Rochester, St Louis, Tampa
- Age
- 6 years and over
- People
- 65 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT06865482 - Phase 2Not yet taking people in United StatesGV101 for Friedreich's Ataxia (FA) Treatment
- Where
- Eatontown
- Age
- 16 years to 40 years
- People
- 48
- Run by
- Graviton Bioscience Corporation
See details and how to joinNCT07870590 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
- Where
- Chicago, Dallas, Eatontown, Tampa
- Age
- 12 years to 40 years
- People
- 150 worldwide
- Run by
- Larimar Therapeutics, Inc.
See details and how to joinNCT07778836 · EU 2025-521628-31-00 - No phaseTaking peopleBiomarkers in Friedreich's Ataxia
- Where
- Gainesville
- Age
- 6 years to 70 years
- People
- 203
- Run by
- University of Florida
See details and how to joinNCT02497534 - Phase 1Taking peoplePhase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
- Where
- New York
- Age
- 12 years to 50 years
- People
- 25
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT05302271 - No phaseTaking peopleCardiac Output and Fatigue in Friedreich's Ataxia
- Where
- New York
- People
- 30
- Run by
- Scott Barbuto
See details and how to joinNCT07444333 - Phase 2Taking peopleStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Tampa
- Age
- 6 years and over
- People
- 26
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - No phaseTaking peopleFriedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
- Where
- Atlanta, Columbus, Denver, Gainesville, Iowa City, Los Angeles, Memphis, Philadelphia, Tampa
- People
- 3,000 worldwide
- Run by
- Friedreich's Ataxia Research Alliance
See details and how to joinNCT06016946 - Phase 3Not yet taking people in United StatesLong-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
- Where
- Iowa City, Los Angeles, Philadelphia, Tampa
- Age
- 7 years to 21 years
- People
- 120 worldwide
- Run by
- PTC Therapeutics
See details and how to joinNCT07681713 · EU 2026-526947-37-00 - No phaseTaking peopleCharacterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
- Where
- New York
- Age
- 12 years to 50 years
- People
- 100
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT02316314 - No phaseTaking peopleA Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
- Where
- Morrisville
- Age
- 16 years and over
- People
- 10
- Run by
- Biogen
See details and how to joinNCT06628687 - No phaseEnrolling by invitationGABA and GSH in FRDA
- Where
- Philadelphia
- Age
- 8 years to 16 years
- People
- 60
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT07635030 - No phaseTaking peopleA Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
- Where
- Aurora, Gainesville, Los Angeles, Philadelphia
- Age
- 16 years and over
- People
- 300 worldwide
- Run by
- Biogen
See details and how to joinNCT06623890